###begin article-title 0
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.
###end p 1
###begin p 2
Present address: Department of Paediatrics and Paediatric Neurology, University Medical Centre Gottingen (UMG), Germany.
###end p 2
###begin p 3
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 3
###begin p 4
###xml 389 396 <span type="species:ncbi:9606">patient</span>
###xml 601 606 <span type="species:ncbi:10090">mouse</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 940 945 <span type="species:ncbi:10090">mouse</span>
Skeletal muscle requires an efficient and active membrane repair system to overcome the rigours of frequent contraction. Dysferlin is a component of that system and absence of dysferlin causes muscular dystrophy (dysferlinopathy) characterized by adult onset muscle weakness, high serum creatine kinase levels and a prominent inflammatory infiltrate. We have observed that dysferlinopathy patient biopsies show an excess of immature fibres and therefore investigated the role of dysferlin in muscle regeneration. Using notexin-induced muscle damage, we have shown that regeneration is attenuated in a mouse model of dysferlinopathy, with delayed removal of necrotic fibres, an extended inflammatory phase and delayed functional recovery. Satellite cell activation and myoblast fusion appear normal, but there is a reduction in early neutrophil recruitment in regenerating and also needle wounded muscle in dysferlin-deficient mice. Primary mouse dysferlinopathy myoblast cultures show reduced cytokine release upon stimulation, indicating that the secretion of chemotactic molecules is impaired. We suggest an extension to the muscle membrane repair model, where in addition to fusing patch repair vesicles with the sarcolemma dysferlin is also involved in the release of chemotactic agents. Reduced neutrophil recruitment results in incomplete cycles of regeneration in dysferlinopathy which combines with the membrane repair deficit to ultimately trigger dystrophic pathology. This study reveals a novel pathomechanism affecting muscle regeneration and maintenance in dysferlinopathy and highlights enhancement of the neutrophil response as a potential therapeutic avenue in these disorders.
###end p 4
###begin title 5
INTRODUCTION
###end title 5
###begin p 6
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C1">1</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C2">2</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C3">3</xref>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C4">4</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C4">4</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C6">6</xref>
###xml 446 468 446 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fer-1</italic>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C2">2</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C7">7</xref>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C7">7</xref>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C8">8</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C2">2</xref>
###xml 874 875 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C9">9</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C11">11</xref>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C12">12</xref>
###xml 995 997 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C14">14</xref>
###xml 1114 1116 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C15">15</xref>
###xml 1321 1323 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C16">16</xref>
###xml 1324 1326 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C17">17</xref>
###xml 1561 1563 1561 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C16">16</xref>
###xml 1564 1566 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C17">17</xref>
###xml 1777 1779 1777 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C18">18</xref>
###xml 1780 1782 1780 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C19">19</xref>
###xml 2497 2499 2497 2499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C20">20</xref>
###xml 2598 2600 2598 2600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C21">21</xref>
###xml 2696 2698 2696 2698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C22">22</xref>
###xml 3027 3029 3027 3029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C23">23</xref>
###xml 3165 3167 3165 3167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C23">23</xref>
###xml 3168 3170 3168 3170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C26">26</xref>
###xml 446 468 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 1159 1164 <span type="species:ncbi:10090">mouse</span>
###xml 1801 1809 <span type="species:ncbi:9606">patients</span>
###xml 1907 1912 <span type="species:ncbi:10090">Mouse</span>
Mutations in the dysferlin gene cause limb-girdle muscular dystrophy type 2B (LGMD2B), Miyoshi myopathy (1,2) and distal anterior compartment myopathy (3,4), collectively known as the dysferlinopathies. These conditions present typically with adult onset, progressive muscle weakness, highly elevated serum creatine kinase (CK) levels and a prominent inflammatory infiltrate in skeletal muscle (4-6). Dysferlin is named after its homology to the Caenorhabditis elegans fertility factor fer-1 (2,7) involved in maturation of spermatids by fusing large vesicles with the plasma membrane. It is a class II membrane protein, containing multiple C2 domains (7,8), inferring that, like many C2 domain-containing proteins, dysferlin is involved in vesicle fusion (2). Dysferlin interacts with various proteins including affixin, AHNAK, annexin A1 and A2, calpain-3 and caveolin-3 (9-11). The annexins and AHNAK are found in the enlargeosome, a calcium-regulated vesicle capable of rapid exocytosis (12-14) and both dysferlin and caveolin-3 traffic via the late endosomal compartment, from which the enlargeosome derives (15). A deficiency of membrane resealing in a mouse model of dysferlinopathy is consistent with the theory that dysferlin is involved in the fusion of vesicles from the enlargeosome with the plasma membrane (16,17). The 'membrane repair hypothesis' postulates that dysferlin is a key component of the muscle membrane repair system, which forms vesicle plugs over membrane lesions, maintaining cell homeostasis before the formation of new membrane (16,17). Recent studies have identified a further component of the muscle resealing apparatus, MG53, which responds early to membrane breaches and may serve to aggregate the membrane repair complex at the sarcolemma (18,19). Dysferlinopathy patients usually develop muscular dystrophy in adult life, following a period of good muscle performance. Mouse models of dysferlinopathy have a mild muscle phenotype, as do MG53 knockout animals. However, the link between the failure of membrane repair and the ultimate development of a muscular dystrophy remains unclear. We were therefore interested to explore how cumulative damage might be implicated in the development of disease and focused our attention on the next stage of muscle response to injury, whereby a muscle fibre undergoes regeneration. This process requires multiple cell types to work in synchrony, producing new contractile tissue in a few days, even after massive injury (20). Signalling from damaged tissue initiates rapid recruitment of neutrophils from the circulation (21). After 24-48 h, signalling from neutrophils and satellite cell populations attract monocytes (22), which are initially pro-inflammatory and phagocytose cellular debris. Activated satellite cells then start to proliferate and migrate to the injury site. Then, the monocyte population switches to an anti-inflammatory phenotype, differentiating into macrophages, which clear cellular debris and induce satellite cells to fuse (23). Studies have shown that the depletion of inflammatory cells has a marked effect on the eventual outcome of the regenerative process (23-26).
###end p 6
###begin p 7
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C27">27</xref>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 270 275 <span type="species:ncbi:10090">mouse</span>
We demonstrate that dysferlin-deficient patients show an increase in immature fibres as defined by neonatal myosin (neo-MHC) labelling, suggesting that the regenerative process is delayed or incomplete in dysferlinopathy. Inducing muscle damage in the C57BL/10.SJL-Dysf mouse model of dysferlinopathy (27) demonstrates attenuated muscle regeneration. There is delayed early neutrophil recruitment, failure of clearance of necrotic fibres and a prolonged inflammatory infiltrate that correlates with a delay in the recovery of contraction force. The cumulative result of sequential impaired regeneration may be key to the ultimate development of a dystrophic phenotype in dysferlinopathy.
###end p 7
###begin title 8
RESULTS
###end title 8
###begin title 9
###xml 16 24 <span type="species:ncbi:9606">patients</span>
Dysferlinopathy patients show a higher number of immature fibres than muscular dystrophy controls
###end title 9
###begin p 10
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F1">1</xref>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 825 826 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F1">1</xref>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
###xml 479 486 <span type="species:ncbi:9606">patient</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
###xml 664 672 <span type="species:ncbi:9606">patients</span>
We assessed the number of immature fibres, as defined by neo-MHC expression, in 10 molecularly confirmed LGMD2B patients from the NCG rare neuromuscular disease service archives. Labelling on muscle sections was independently analysed blindly by two experienced investigators (R.B. and R.C.). The average percentage of fibres labelled with neo-MHC was compared with 16 LGMD2A patients, six dystrophinopathy patients and six LGMD2I patients (Fig. 1). Although the samples vary in patient age and stage of pathology, dysferlinopathy patients have a consistently higher percentage of neo-MHC-positive fibres (56.3%) than other muscular dystrophies, especially LGMD2A patients (13.9%; P < 0.01 Mann-Whitney). These fibres do not show utrophin labelling, suggesting that these are not fibres at early stages of regeneration (Fig. 1).
###end p 10
###begin p 11
###xml 69 70 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 362 363 354 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 536 537 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 554 555 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 582 583 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 109 116 <span type="species:ncbi:9606">patient</span>
###xml 432 439 <span type="species:ncbi:9606">patient</span>
###xml 485 492 <span type="species:ncbi:9606">patient</span>
Dysferlinopathy patients show an excess of neo-MHC positive fibres. (A) Serial sections of a dysferlinopathy patient biopsy showing the characteristic extensive labelling for neo-MHC without up-regulation of utrophin or laminin-alpha5 by immunohistochemistry. Red stars identify specific neo-MHC positive fibres in the serial sections. Scale bar is 100 microm. (B) Mean percentage of fibres showing positive staining for neo-MHC in patient biopsies (+/-SEM). The causative gene of the patient groups is shown under the graph. Dysferlin n = 10, calpain-3 n = 16, FKRP and dystrophin n = 6.
###end p 11
###begin title 12
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Muscle pathology is mild but progressive in dysferlin-deficient C57BL/10.SJL-Dysf mice
###end title 12
###begin p 13
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C27">27</xref>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F2">2</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
We performed a thorough characterization of muscle pathology in the C57BL/10.SJL-Dysf mice (27) studying different muscle groups by histochemistry up to 1 year of age. Overt dystrophic changes are limited to specific muscle groups in older animals (data not shown). The tibialis anterior (TA) muscle was the target for our regeneration studies and studied for force generation. Even at 1 year of age, there is limited pathology in the TA, with some thickening of the perimysial connective tissue and a small number of central nuclei (Fig. 2A and B). Between 10 and 14 weeks of age, when the majority of our studies were performed, we observed only a small percentage of centrally localized nuclei. The limited overt pathology in the TA at this stage allowed us to investigate the effects of dysferlin deficiency in the absence of pre-existing dystrophic changes and secondary effects such as inflammation.
###end p 13
###begin p 14
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 126 127 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 292 293 288 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 336 337 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 357 361 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 363 364 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 374 377 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 379 380 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 393 394 389 390 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 470 471 466 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 543 544 539 540 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 740 744 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 764 767 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 240 245 <span type="species:ncbi:10090">mouse</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
Characterization of the C57BL/10.SJL-Dysf mouse. Tibialis anterior muscle from 1-year-old C57BL/10 (A) and C57BL/10.SJL-Dysf (B) stained with van Gieson/Haematoxylin showing increased perimysial connective tissue in the dysferlin-deficient mouse, but limited pathology. Scale bar 50 microm. (C) Specific force generation from C57BL/10 (n = 7), C57BL/10.SJL-Dysf (n = 7) and mdx (n = 4) mice. (D) Percentage drop in force following a single 40% lengthening contraction. (E) Percentage drop in force following two lengthening 40% contractions. (F) Serum creatine kinase 0, 1, 4 and 7 days post-exhaustive exercise. Median values are shown within the graph. Graphs show mean values (+/-SEM). C57BL/10 is represented by open bars, C57BL/10.SJL-Dysf by closed bars and mdx by hatched bars.
###end p 14
###begin title 15
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Mild muscle weakness is seen in C57BL/10.SJL-Dysf mice
###end title 15
###begin p 16
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F2">2</xref>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C28">28</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F2">2</xref>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F2">2</xref>
###xml 739 742 739 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
We assessed C57BL/10.SJL-Dysf, C57BL/10 and mdx mice at 12-14 weeks of age using in situ force measurement. C57BL/10.SJL-Dysf animals had a reduced specific force (median 262 kN/m2 in C57BL/10, 232 kN/m2 in C57BL/10.SJL-Dysf and 178 kN/m2 in mdx; P < 0.05 for each; Mann-Whitney, Fig. 2C). Maximum isometric twitch and tetanic forces in the C57BL/10.SJL-Dysf strain were not significantly reduced. The muscle was put through an eccentric (lengthening) contraction protocol (28), whereby a 40% lengthening contraction is used to damage the muscle. The dysferlin-deficient muscle showed no significant difference from control in the recovery of force generation after one (Fig. 2D) and two lengthening contractions (Fig. 2E), in contrast to mdx.
###end p 16
###begin p 17
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C27">27</xref>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F2">2</xref>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F2">2</xref>
###xml 679 683 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
We also assessed dysferlin-deficient animals following eccentric exercise induced by exhaustive downhill running. The exhaustion times for C57BL/10.SJL-Dysf were reduced, although not significantly (C57BL/10 median 45 min, C57BL/10.SJL-Dysf 39 min, P = 0.0532 Mann-Whitney). Contrary to our previous report (27), serum CK levels were significantly elevated even without exercise (C57BL/10 median 480 IU/l, C57BL/10.SJL-Dysf 980 IU/l, P < 0.002 Mann-Whitney; Fig. 2F). In both strains, serum CK levels 1 day after exercise rose, returning to pre-exercise levels at day 4, before a second peak at 7 days post-exercise (Fig. 2F). Although this second peak is higher in C57BL/10.SJL-Dysf suggesting a persistence of muscle damage in this strain compared with control, the high variance in these observations makes further conclusions tentative.
###end p 17
###begin p 18
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Dysferlin-deficient mouse muscle is therefore slightly weaker than control, but is not more susceptible to immediate damage, showing none of the characteristic susceptibility to contraction-induced injury seen in mdx.
###end p 18
###begin title 19
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Muscle regeneration is impaired and attenuated in C57BL/10.SJL-Dysf mice, with delay in recovery of muscle function after notexin treatment
###end title 19
###begin p 20
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C29">29</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C30">30</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F3">3</xref>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 899 900 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F3">3</xref>
###xml 1002 1006 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 1194 1202 1194 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1-Kcam</sup>
###xml 1204 1206 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C16">16</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 1007 1012 <span type="species:ncbi:10090">mouse</span>
C57BL/10 and C57BL/10.SJL-Dysf mice were injected with notexin (29,30) in the TA muscle of one hindlimb and the animals allowed to recover for up to 28 days. Sections of the muscle stained with H&E are shown in Figure 3A. Dysferlin-deficient muscle initially showed a lower concentration of mononuclear cells (3 days post-injection), but there was striking failure to resolve the inflammatory process, continuing beyond the point where the muscle was repaired in control mice. Later stage regenerating C57BL/10.SJL-Dysf muscle (7 and 14 days post-injection) is characterized by darkly staining red fibres, which remain anuclear and appear to provide foci for the ongoing inflammatory response. Alizarin red staining identifies abnormal sarcoplasmic accumulations of calcium. Such fibres persist in dysferlin-deficient muscle beyond the point where they have been cleared in the control muscle (Fig. 3A). We conclude that notexin-induced regeneration is impaired in the dysferlin-deficient C57BL/10.SJL-Dysf mouse with delayed removal of necrotic fibres. To confirm that this is a feature of dysferlinopathy, the regeneration defect after notexin treatment has also been demonstrated in the Dysftm1-Kcam (16) dysferlin-deficient strain (A).
###end p 20
###begin p 21
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 281 282 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 432 433 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 442 443 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 458 459 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 477 481 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 485 486 483 484 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 540 544 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 723 727 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
Muscle regeneration following notexin injury is impaired in dysferlin-deficient mice. (A) TA muscle from notexin injected mice after 3, 7 or 14 days of recovery and uninjected (control) were stained with haematoxylin and eosin or alizarin Red which detects intracellular calcium. (B) Mean specific force (+/-SEM) 7 days following notexin injection. Significant deficit in force recovery was found in the dysferlin-deficient strain (P < 0.05; n = 5 C57BL/10, n = 6 C57BL/10.SJL-Dysf). (C) H&E stained sections from C57BL/10 and C57BL/10.SJL-Dysf animals untreated (control), and following a single or three consecutive treatment(s) with notexin to induce muscle regeneration. Three injections of notexin in the C57BL/10.SJL-Dysf strain induce a marked dystrophic phenotype with variation in fibre size, inflammatory infiltration and necrotic fibres, whereas the control (C57BL/10) strain is capable of effective regeneration. Scale bars 100 microm.
###end p 21
###begin p 22
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F3">3</xref>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
To look for correlation between the delayed removal of necrotic cells following injury and impairment of muscle function, in situ force measurement studies were performed on the notexin injected TA muscles of C57BL/10 and C57BL/10.SJL-Dysf mice after 7 and 14 days. Neither strain had recovered full muscle function even at 14 days post-injection. Recovery of the specific force was significantly impaired in dysferlin-deficient mice at 7 days post-notexin treatment (Fig. 3B). Specific force was reduced from 91% of wild-type levels in the untreated to 65% of wild-type levels at 7 days after notexin injection. Median values of maximum isometric force were also significantly reduced at 14 days post-notexin and median values of both maximum isometric tetanic and specific force suggested that the recovery of these contraction parameters was also delayed; however, the results were not statistically significant (data not shown).
###end p 22
###begin title 23
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Repeated cycles of degeneration/regeneration result in a striking dystrophic phenotype in C57BL/10.SJL-Dysf mice
###end title 23
###begin p 24
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 589 593 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 752 753 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F3">3</xref>
###xml 946 950 946 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
To further challenge the regenerative capacity of dysferlin-deficient muscles, C57BL/10.SJL-Dysf and C57BL/10 TA muscles of female mice aged 10-12 weeks were subjected to three rounds of notexin injection, 14 days apart. The muscles were harvested 3 or 8 weeks later. Three weeks following triple notexin treatment not only the C57BL/10.SJL-Dysf but also the control muscle was severely affected, showing equal extensive necrosis and inflammatory infiltrate (data not shown). However, the control muscle was able to fully repair by 8 weeks post-injection, whereas muscle from C57BL/10.SJL-Dysf showed a classical dystrophic pattern with fibrous tissue, variation in fibre size, an ongoing inflammatory process and darkly staining necrotic fibres (Fig. 3C). We conclude that repeated cycles of inflammatory insult and attenuated regeneration, act cumulatively to accelerate the development of a persistent dystrophic phenotype in the C57BL/10.SJL-Dysf muscle.
###end p 24
###begin title 25
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Satellite cell activation and myoblast fusion during regeneration appear normal in C57BL/10.SJL-Dysf mice
###end title 25
###begin p 26
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C31">31</xref>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myf5</italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myog</italic>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax7</italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdk1b</italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F4">4</xref>
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 997 998 997 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F4">4</xref>
As activated satellite cells express dysferlin (31), we investigated the possibility that a failure to activate the satellite cell population was responsible for impaired regeneration in dysferlin-deficient muscle. Quantitative PCR (qPCR) analysis of various markers of satellite cell activation and differentiation, Myf5, Myog, Pax7 and Cdk1b (p27) showed no significant difference in any of these transcripts (Fig. 4A). The inherent variability of transcript levels at 3-4 days post-injection means that small differences at this stage would be difficult to detect without a much larger sample. However, the general pattern of expression of satellite cell markers is not markedly disturbed in the dysferlin-deficient strain suggesting that the defect in regeneration does not lie in an intrinsic defect of satellite cells. Indeed, injured muscles stained for desmin (a marker for myoblasts and early stage myotubes) show that C57BL/10.SJL-Dysf myoblasts fuse and form myotubes effectively (Fig. 4B). At 14 days, the difference in the regenerative process between the two strains appeared more to relate to failure of clearance of necrotic tissue than the ability to form new desmin positive fibres. This prompted us to analyse the inflammatory cell component during regeneration in this model.
###end p 26
###begin p 27
###xml 121 122 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 344 345 344 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Satellite cell activation and fusion are not markedly perturbed during muscle regeneration in dysferlin deficient mice. (A) Quantitative RT-PCR analysis of transcripts involved in myogenesis and satellite cell fusion. There were no significant differences between the C57BL/10 (open bars) and C57BL/10.SJL-Dysf (closed bars) by two-way ANOVA. (B) Immunohistochemical analysis of desmin expression in muscle 3, 5, 7 and 14 days following notexin-induced regeneration identifies the fusing myotubes. Multiple small myotubes were present in the dysferlin deficient muscle, indicating the potential to fuse, although there was also necrotic fibres and extensive inflammatory infiltration. Variability in the appearance of the periphery (left panel) versus the centre (right panel) of the regenerating area is shown for C57BL/10.SJL-Dysf at day 7 and 14.
###end p 27
###begin title 28
Dysferlin-deficient muscle shows early changes in the inflammatory cell infiltrate with reduced neutrophil recruitment following injury
###end title 28
###begin p 29
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F5">5</xref>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 807 809 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 816 818 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 892 899 892 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 933 935 933 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 942 944 942 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1021 1023 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C23">23</xref>
###xml 1217 1218 1217 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F5">5</xref>
###xml 1113 1117 <span type="species:ncbi:10090">mice</span>
Muscle sections at 3, 5 and 7 days after notexin injection were stained for Ly-6G, a neutrophil marker (Fig. 5A) and positive cells counted in seven random fields throughout the damaged area. The numbers of Ly-6G-positive cells at day 3 were significantly reduced in dysferlin-deficient animals (P < 0.01). In order to confirm the attenuation of neutrophil recruitment, the inflammatory cell component of regenerating muscle was analysed by flow cytometry. Muscle from C57BL/10.SJL-Dysf and control animals through the course of notexin-induced regeneration was disaggregated, and the inflammatory cells were separated on CD45 expression. In both strains, the process of regeneration recapitulates a classical pattern with an early invasion of neutrophils, followed by a population of pro-inflammatory Ly-6Chi, F4/80lo monocytes recruited 1-3 days post-injection. These monocytes then switch in situ to become anti-inflammatory Ly-6Clo, F4/80hi macrophages, as the inflammatory phase is resolved 4-7 days post-injection (23). The switch from monocytes to macrophages appears unaffected in the dysferlin-deficient mice, and the qualitative pattern of inflammatory cell recruitment was similar in the two strains (Fig. 5B).
###end p 29
###begin p 30
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 510 511 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 674 678 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 829 831 825 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 838 840 834 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 877 879 873 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 885 887 881 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 891 892 887 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1041 1042 1037 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1107 1111 1103 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
FACS analysis of notexin-induced regeneration indicates a reduced early neutrophil recruitment in dysferlin deficient muscle. (A) Muscle from C57BL/10 and C57BL/10.SJL-Dysf strains 3, 5 and 7 days after notexin-induced regeneration stained with an antibody against the neutrophil marker Ly-6G, developed with DAB (dark brown) and counterstained with haematoxylin to show nuclei (blue). Significantly (P < 0.01) fewer neutrophils were observed at day 3 in the C57BL/10.SJL-Dysf strain. Scale bar is 50 microm. (B) Frequency plots of CD45-positive mononuclear cells extracted from muscle 0, 1, 3, 4 or 7 days after notexin injection in either the C57BL/10 or the C57BL/10.SJL-Dysf strain. Each dot represents a single event from the cytometer. Circles identify the monocyte populations showing the shift from pro-inflammatory Ly-6Chi/ F4-80lo into the macrophage precursor (Ly-6Clo/F4-80hi). (C) Numbers of CD45-positive cells, neutrophils and monocytes/macrophages extracted from the FACS data and normalized for mass of tissue. Significant (P < 0.01) differences between C57BL10 (open bars) and C57BL10.SJL-Dysf (closed bars) were found for total CD45 cells at 3 days after notexin injury and numbers of invading neutrophils at 1, 2 and 3 days after notexin injury.
###end p 30
###begin p 31
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F5">5</xref>
###xml 552 554 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 718 725 718 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C23">23</xref>
###xml 767 769 767 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 802 804 802 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 888 889 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1017 1019 1017 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
However, quantitative analysis of cell numbers showed a significant reduction in the number of neutrophils in the C57BL/10.SJL-Dysf mice at 1, 2 and 3 days post-injection compared with wild-type (Fig. 5C). There was also a significant reduction in the numbers of CD45-positive cells at 3 days post-injection. Monocyte populations also showed reduction in numbers at days 1-3, as would be expected since neutrophils secrete factors to recruit monocytes. In the early stages of regeneration (days 1-2), this difference was found specifically in the Ly-6Chi monocyte population, although this failed to reach statistical significance. These represent the monocytes recruited from the circulation which then differentiate in situ (23) into the macrophage precursor (Ly-6Clo) population. At day 3, the Ly-6Clo monocyte population showed a significant reduction in dysferlin-deficient animals (P < 0.02). This indicates a generalized failure of monocyte recruitment with a concomitant reduction in the pro-macrophage (Ly-6Clo) cell type at day 3 where phagocytosis of necrotic fibres peaks in the notexin model.
###end p 31
###begin title 32
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
Needle wounding of C57BL/10.SJL-Dysf muscle confirms a defect in neutrophil recruitment
###end title 32
###begin p 33
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F6">6</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F6">6</xref>
###xml 790 798 790 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1-Kcam</sup>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C16">16</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
Needle wounding is a simpler and more confined event than notexin injection and we hypothesized that impaired neutrophil recruitment would also be apparent in needle wounded dysferlin-deficient muscles. Four TAs from C57BL/10.SJL-Dysf and control C57BL/10 mice were wounded with a hypodermic syringe needle and the muscle collected after 6 h. Serial sections of the muscle were immunostained for Ly-6G to identify the initial wave of infiltrating neutrophils. Histology showed reduced neutrophil recruitment to the site of injury in dysferlin-deficient muscle (Fig. 6A), and quantification of the number of infiltrating neutrophils around the site of injury confirmed this observation (Fig. 6B). The neutrophil recruitment defect after needle wounding has also been demonstrated in the Dysftm1-Kcam (16) dysferlin-deficient strain (B).
###end p 33
###begin p 34
###xml 80 81 80 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 281 282 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 435 439 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
Ly-6G staining and needle wounding confirm a defect in neutrophil recruitment. (A) Needle wounded muscle from C57BL/10 and C57BL/10.SJL-Dysf was harvested 6 h after wounding and stained with H&E and by immunohistochemistry for the neutrophil marker Ly-6G. Scale bar is 50 microm. (B) Counts of cells per unit area confirm the visual observation that significantly more neutrophils are present in C57BL/10 (open bars) than C57BL/10.SJL-Dysf (closed bars) 6 h after needle wounding.
###end p 34
###begin title 35
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
Reduced MCP-1 secretion by C57BL/10.SJL-Dysf myoblasts
###end title 35
###begin p 36
###xml 818 819 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 835 836 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F7">7</xref>
###xml 1211 1212 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1261 1262 1257 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F7">7</xref>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 663 669 <span type="species:ncbi:10090">murine</span>
Since cytokines are important for inflammatory cell recruitment, we hypothesized that dysferlin might play a role in the release of cytokines or chemokines. Primary myoblasts were derived from wild-type and dysferlin-deficient neonatal mice to investigate cytokine release in the two strains as a possible explanation for poor neutrophil recruitment. The cells were stimulated with 200 U/ml IFN-gamma for 24 h before supernatant and cells were collected. MCP-1, MIP-2 and IL-6 secreted into the medium was measured by ELISA and normalized by total protein levels in the cell lysate. MIP-2 and IL-6 are not detectable at steady state in the medium or the cells of murine primary myoblasts. However, there was a highly significant reduction in the MCP-1 released into the medium by stimulated dysferlin-deficient cells (P < 0.001) (Fig. 7). This indicates that there is an impairment of cytokine release in dysferlin-deficient muscle cells on direct stimulation. To confirm that the cytokine release in response to membrane wounding was also impaired this assay was repeated using 0.005% saponin to induce membrane wounds. MCP-1 secretion by dysferlin-deficient cells using this technique was also significantly (P < 0.001) impaired relative to the control (Fig. 7).
###end p 36
###begin p 37
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
Dysferlin deficient primary myoblasts show impaired secretion of MCP-1 on stimulation. The concentration of MCP-1 was assayed by ELISA in the medium of primary myoblast cells derived from neonatal C57BL/10 (open bars) and C57BL/10.SJL-Dysf (closed bars) 24 h after stimulation with interferon gamma or treatment with 0.005% saponin. ND, not detected (MCP-1 was below the threshold for detection in the ELISA).
###end p 37
###begin title 38
DISCUSSION
###end title 38
###begin p 39
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C16">16</xref>
###xml 998 999 998 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F8">8</xref>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
###xml 730 738 <span type="species:ncbi:9606">patients</span>
In 2003, Bansal et al. (16) demonstrated that dysferlin-deficient myotubes have a defect in membrane repair, leading to the hypothesis that failure to repair sarcolemmal damage following injury causes loss of cell homeostasis and cell death. Cumulative experience from the natural history of dysferlinopathy in patients and animal models and now also from the MG53 knockout demonstrates that the development of early severe muscular dystrophy is not a feature of defective muscle membrane repair. We became interested in a possible perturbation of the regenerative process both because it represents a longer term response to injury and also because of our observation of an increased number of immature fibres in dysferlinopathy patients compared with disease controls. We believe that the patch hypothesis of dysferlin function can be extended to put emphasis also on the content of the vesicles which fuse at the cell membrane after muscle injury, including neutrophil chemotactic factors (Fig. 8). Failure of the release of cytokines from damaged muscle could account for the impairment of inflammatory cell recruitment at an early stage of regeneration with subsequent incomplete muscle remodelling, resulting in the persistence of inflammatory cells and necrotic fibres, and over time, the development of muscular dystrophy.
###end p 39
###begin p 40
###xml 111 112 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 234 235 234 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 421 422 421 422 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Hypothetical mechanism linking membrane repair with neutrophil recruitment in normal muscle. A membrane wound (A) such as physical injury or exercise induced tear, induces the calcium dependent fusion of vesicles with the sarcolemma (B) under the control of dysferlin. This releases vesicle contents, the hypothesized neutrophil chemotactic factors and reseals the membrane. Dysferlin continues to induce vesicle fusion (C) to set up a chemotactic gradient which directs neutrophils directly to the fibre, and specific region of the fibre, which was wounded.
###end p 40
###begin p 41
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C23">23</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C10">10</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C16">16</xref>
###xml 1208 1209 1208 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP121F8">8</xref>
This hypothesis is based on the known function of dysferlin and other ferlin proteins as well as the expression pattern of dysferlin in blood, which is restricted to the type II (non-classical) monocyte population (data not shown). Dysferlin is not expressed at an appreciable level in neutrophils, and so the deficient neutrophil response is unlikely to be due to functional differences between dysferlin-deficient and wild-type neutrophils. The dysferlin positive monocyte population is distinct from those which initially invade muscle following injury (23), so it is unlikely that monocyte expression of dysferlin is involved in the defective regeneration, since the type II monocytes are not involved until after the resolution of the inflammatory phase where regeneration of dysferlinopathic muscle is already abnormal. The well-established function of dysferlin in fusion of vesicles with the plasma membrane (10,16) and the observation of reduced cytokine release by dysferlin-deficient cells provide an alternative explanation, that part of the function of dysferlin is to release cytokines from internal vesicles in order to attract neutrophils to the site of injury. The model presented in Figure 8 is based on the assumption that the primary site of dysferlin action is the mature myofibre. An equally acceptable model could be conceived where dysferlin acts to secrete chemotactic factors from activated satellite cells or tissue resident macrophages (which derive from type II monocytes) and would also be found at the injury site, although not in the early stages when the neutrophil recruitment defect can already be demonstrated. This hypothesis remains tentative until some of the underlying assumptions have been tested.
###end p 41
###begin p 42
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C23">23</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C30">30</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C32">32</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C31">31</xref>
Notexin injection is a well understood method for studying the process of muscle regeneration in animal models (23,30,32). Previous studies have indirectly suggested many ways that dysferlin could be involved in regeneration, including a possible role in satellite cell activation or fusion (31). Our data suggest the defect is not at the level of the satellite cell, as the expression pattern of genes involved in satellite cell activation and differentiation are not altered, and myoblasts appear to fuse normally. On the other hand, we show a significant reduction in neutrophil recruitment and a failure to clear necrotic fibres in regenerating dysferlin-deficient muscle: in keeping with the abnormal histology, there is reduced recovery of muscle force.
###end p 42
###begin p 43
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C33">33</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C34">34</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C35">35</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C36">36</xref>
Following muscle injury, inflammatory cells are recruited to the injury site in an orderly manner. Neutrophils and monocytes coexist at the site of damage, suggesting that they have different, complementary functions. It is known that neutrophils produce oxidizing agents that can destroy cell membranes in the absence of other inflammatory cells (33), and blocking neutrophil function results in significantly diminished early tissue destruction (34). Monocytes are not responsible for membrane disruption, but their reparative functions are inhibited by the absence of neutrophils (35,36). Therefore, specific neutrophil functions are necessary for tissue repair and the interactions between neutrophils and monocytes appear essential to physiological regeneration. It is clear that the impaired neutrophil recruitment is not a consequence of the delayed regenerative process, since this effect precedes any perturbation in muscle regeneration and can also be observed shortly after needle wounding.
###end p 43
###begin p 44
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C24">24</xref>
There is already direct evidence that the depletion of the neutrophil population impairs and attenuates muscle regeneration (24), leading to reduction in macrophage numbers and failure to clear necrotic fibres similar to our findings. The complete neutropenia induced in these studies is more extreme than the situation in dysferlinopathy, where only a partial reduction in neutrophil recruitment is observed. The moderate reduction in macrophage recruitment observed in our studies is also consistent with these data, where total neutropenia resulted in only an approximately50% reduction in macrophage numbers. This is most likely due to the existence of neutrophil independent mechanisms of macrophage recruitment and a non-linear relationship between neutrophil signalling and macrophage response.
###end p 44
###begin p 45
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C6">6</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C37">37</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C38">38</xref>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
The inflammatory phase of muscle regeneration in our model persists beyond the stage where it has resolved in the control animals. This is entirely consistent with the human situation in dysferlinopathy where a persistent inflammatory infiltrate is common (6) possibly reflecting a failure of muscle remodelling following partial regeneration. We hypothesise that both in this model system and in the dystrophic patients, the persistent necrotic fibres provide foci for an ongoing inflammatory reaction. An increasingly pro-inflammatory milieu develops from successive rounds of poor regeneration, increasing the tissue load of both necrotic and inflammatory cells and directing myogenic cells towards a fibrotic fate (37,38).
###end p 45
###begin p 46
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C32">32</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C18">18</xref>
###xml 227 232 <span type="species:ncbi:10090">mouse</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 900 908 <span type="species:ncbi:9606">patients</span>
We have confirmed previous data (32) that the established membrane repair defect in dysferlinopathic muscle does not appear to cause acute exercise intolerance which is in contradistinction to the findings in the MG53 knockout mouse, despite an apparently comparable membrane resealing defect. Careful analysis of these animal models in the future may help to demonstrate the relative contributions of these different proteins to the process of repair and subsequent recovery. For example, it is possible to speculate that if the reduction in early neutrophil recruitment is specific to dysferlin deficiency, the normal neutrophil response in the MG53 knockout could contribute to the acute damage observed (18). Our finding of slight weakness, but no susceptibility to lengthening contractions in the dysferlin-deficient mice is consistent with this interpretation and the clinical situation, where patients generally develop weakness at a late stage and following a period of pre-symptomatic hyperCKaemia. This expanded model of disease pathogenesis explains a number of unusual features of the disease, including the late onset following a period of good muscle prowess with exercise tolerance and the extensive inflammatory process.
###end p 46
###begin p 47
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C39">39</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C40">40</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C40">40</xref>
###xml 440 448 440 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori</italic>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 1668 1670 1668 1670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 758 766 <span type="species:ncbi:9606">patients</span>
###xml 786 794 <span type="species:ncbi:9606">patients</span>
Previous studies have examined the role of dysferlin in monocytes (39,40) and found evidence of an increased phagocytotic activity (40). However, these authors examined the SJL/J strain and compared these animals with C57BL/6J. Genetic differences between these strains make it difficult to conclude that a global increase in phagocytotic activity is supported, especially given the strongly pro-inflammatory situation in SJL/J which would a priori be expected to increase the activity of phagocytes. Our studies using very similar techniques in C57BL/10-SJL.Dysf indicate no significant difference in the phagocytotic index when compared with the genetically equivalent C57BL/10 (data not shown). These authors also examined phagocytes from dysferlinopathy patients. However, in these patients, there is commonly an ongoing inflammatory process in the muscle which would also be expected to increase phagocyte activity. The assay used, both in our laboratory and others, is a simple measure of the phagocyte ability to engulf fluorescent particles, whereas the process that we are examining in this study (the clearance of necrotic fibres by both neutrophils and macrophages) is much more complex, requiring tight control in order to initiate the orderly inflammatory process that degrades damaged tissue without damaging healthy cells. We believe that it is this cascade, rather than the process of phagocytosis itself which is defective here. It is, however, also important to consider that an additional factor in the resolution of regeneration might reside in the monocyte population, which also express dysferlin. Dysferlin is specifically expressed in the Ly-6Clo, pre-macrophage population which is not recruited to the muscle until later in the regenerative process-a defect in this monocyte population therefore does not explain the early neutrophil recruitment defect but requires further investigation in the later stages of regeneration.
###end p 47
###begin p 48
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C41">41</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C42">42</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C43">43</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C10">10</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C16">16</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C44">44</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C45">45</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Although the precise mechanisms responsible for attracting inflammatory cells into damaged tissues remain unclear, mice with engineered mutations in MCP-1 or its receptor CCR2 display impaired skeletal muscle regeneration after injury (41,42). Interestingly, not only inflammatory cells but also satellite cells are responsible for cytokine release (43). We demonstrated that MCP-1 release from dysferlin-deficient myoblasts was significantly reduced relative to wild-type. It is already established that dysferlin translocates to the membrane in response to injury and is responsible for the fusion of vesicles with the sarcolemma (10,16,44,45). Our findings implicate dysferlin in the process of cytokine/chemokine release upon muscle injury.
###end p 48
###begin p 49
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Establishing a link between any postulated molecular mechanism of disease and the end point of in vivo pathology is crucial to the development of targeted therapeutics. Our work emphasises failure of ongoing muscle regeneration and maintenance in addition to the acute response to sarcolemmal damage. Enhancement of the neutrophil response is a potential new therapeutic avenue for dysferlinopathy.
###end p 49
###begin title 50
MATERIALS AND METHODS
###end title 50
###begin title 51
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 51
###begin p 52
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
Patients were identified for this study through the database of the Diagnostic and Advisory Service for Rare Neuromuscular Diseases based at the Muscle Immuno-Analysis Unit (MIU), Newcastle. All patients had a confirmed molecular diagnosis, had been analysed at the MIU and met ethical criteria for inclusion within the study.
###end p 52
###begin title 53
Exercise-induced injury and CK analysis
###end title 53
###begin p 54
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">Mice</span>
We originally obtained dysferlin-deficient C57BL/10.SJL-Dysf mice from Professor Reginald Bittner (Medical University of Vienna). All strains of mice were housed under standard conditions and used according to the Animal Procedures Committee, Home Office, UK and local rules. To acclimatize the mice to the apparatus, mice were run gently downhill on a treadmill inclined at 15degrees for 10 min at 9 m/min on day 1, then 10 min at 10 m/min on day 2 and 10 min at 10 m/min on day 3. On day 4, the mice were run for 10 min at 10 m/min, at which point the speed was increased within a few seconds to 16 m/min. Mice were run to exhaustion at this speed and the time to exhaustion noted. Blood samples were taken via the tail vein and serum isolated for CK analysis.
###end p 54
###begin title 55
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
In situ force measurement
###end title 55
###begin p 56
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C28">28</xref>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C46">46</xref>
###xml 60 64 <span type="species:ncbi:10090">Mice</span>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
This procedure was adapted from standard protocols (28,46). Mice were anaesthetized with an intra-peritoneal injection of hypnorm(R)/hypnovel(R)/water (1:1:2 by volume) at a dosage of 10 ml/kg. Under deep anaesthesia, the distal tendon of the TA muscle was dissected from surrounding tissue and the tendon tied with 4.0 braided surgical silk (Ethicon Inc.). The sciatic nerve was exposed and all its branches cut except for the common peroneal nerve (CPN), which innervates the TA muscle. The mouse was placed on a heated stage (Aurora Scientific Inc.) to maintain body temperature at 37degreesC. The TA tendon was attached to the lever arm of a 305C dual-mode servomotor transducer (Aurora Scientific Inc.).
###end p 56
###begin p 57
TA muscle contractions were elicited by stimulating the distal part of CPN via bipolar platinum electrodes, using supramaximal square-wave pulses of 0.02 ms (701B Stimulator; Aurora Scientific Inc.). Data acquisition and control of the servomotors were conducted using a LabView based DMC program (Dynamic muscle control and Data Acquisition; Aurora Scientific Inc.).
###end p 57
###begin p 58
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 293 294 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 314 315 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sub>
After establishing the force-frequency relationship, we assessed the susceptibility of TA muscles to a lengthening contraction protocol. This consisted of stimulating the muscle at 180 Hz (the frequency that usually resulted in Po) for 500 or 300 ms, then the muscle was lengthened by 40% of Lo at a velocity of 2Lf/s. A second lengthening contraction identical to the first was administered 10 s later and maximum isometric force was measured 1 and 15 min later. At the end of the experiment, muscles were excised, weighed and prepared for histological analysis.
###end p 58
###begin title 59
Muscle injury and muscle preparation
###end title 59
###begin p 60
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 977 982 <span type="species:ncbi:10090">mouse</span>
Notexin (50 microl at 4 microg/ml in 0.9% NaCl; Latoxan) was injected directly into the right TA of 8- to 12-week-old female mice using a 0.5 ml U-100 insulin syringe (the left TA was used as a non-injected control). For multiple injections, the animals were allowed to recover for 14 days between treatments and muscles were harvested 21 or 28 days following the final injection. The TA muscles were excised and rinsed in PBS and embedded in OCT. Serial 10 microm sections were used for the histological analysis or immunohistochemical staining. Haematoxylin and eosin staining was used for morphological analysis and Alizarin Red S was used to detect the necrotic fibres. Images were taken using an Axioplan II microscope (Carl Zeiss, Inc., USA) with Axiovision 4.6 software (Carl Zeiss MicroImaging, Inc.). Quantitative analysis of muscle regeneration was performed on the entire injured area. Ten fields (40x objective; Carl Zeiss MicroImaging, Inc.) were analyzed in each mouse, representing 300-400 fibres per muscle.
###end p 60
###begin title 61
Immunohistochemistry
###end title 61
###begin p 62
###xml 201 202 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 203 204 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Longitudinal or transverse sections of 10 microm were cut using a cryostat and kept at -80degreesC until further processing. Sections were fixed in 4% PFA/TBS for 15 min, followed by incubation in 3% H2O2/TBS for 10 min to block endogenous peroxidase, and blocking of endogenous biotin (Avidin/Biotin Blocking System, DAKO). Sections were then incubated with 2% BSA/TBS for 30 min before application of primary antibody.
###end p 62
###begin p 63
###xml 346 347 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 512 513 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 233 236 <span type="species:ncbi:10116">rat</span>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
###xml 331 337 <span type="species:ncbi:9986">rabbit</span>
###xml 381 387 <span type="species:ncbi:9986">rabbit</span>
###xml 393 396 <span type="species:ncbi:10116">rat</span>
Sections were incubated with one of the following primary antibodies diluted in 2%BSA/TBS; biotinylated mouse anti-human desmin 1:25 (ARKtrade mark Peroxidase kit (K3954, DAKO), clone D33, DAKO) at room temperature for 30 minutes or rat anti-mouse Ly6G 1:1000 (1A8, BD Pharmingen) overnight at 4degreesC. This was followed by anti-rabbit EnVision+-HRP-conjugated polymer (DAKO) or rabbit anti-rat biotinylated secondary antibody 1:200 for 30 minutes, then Streptavidin-HRP conjugate (DAKO) for 15 minutes and DAB+ substrate (Vector laboratories, Inc., Burlingame, CA) for development of peroxidase activity for 10 minutes. Counterstaining of nuclei was performed using Harris haematoxylin (Surgipath) followed by mounting of slides with Aquamount (VWR). Images were acquired using a Zeiss Axioplan microscope coupled to an AxioCam camera and the AxioVision software.
###end p 63
###begin title 64
qPCR
###end title 64
###begin p 65
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax7</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myf5</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myog</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdk1b</italic>
###xml 467 472 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hprt1</italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pgk1</italic>
###xml 734 735 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 796 800 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
TA muscles were harvested before injury (day 0) and 2, 3, 4, 5, 7 and 10 days post-injection with notexin and total RNA was extracted using TRIzol, according to the manufacturer's instruction (Invitrogen). This was followed by reverse transcription of total RNA into cDNA using the Superscript III reverse transcriptase system, according to the manufacturer's instructions (Invitrogen). Relative expression levels of Pax7, Myf5, Myog, Cdk1b (p27) and reference genes Hprt1 and Pgk1 was determined using custom-made primer-probes (PrimerDesign Ltd., Southampton, UK) and the qPCR reactions were run on the ABI PRISMtrade mark 7900 HT Real-Time PCR System (Applied Biosystems, Inc.). All reactions were run in triplicate on TA muscles (n = 5) for each time point for both C57BL/10 and C57BL/10.SJL-Dysf mice.
###end p 65
###begin p 66
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C47">47</xref>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hprt1</italic>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pgk1</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP121C48">48</xref>
Raw data were extracted and analyzed in SDS2.1 (Applied Biosystems, Inc.) using automatic detection of Ct-values, followed by export to qBase (47). Here the Ct-values were quality checked, all triplicates were evaluated and a run was excluded if the difference in Ct within a triplicate >0.5. For all analyses, the data was normalized to the expression of Hprt1 and Pgk1 (reference gene stability was determined using the geNorm Housekeeping gene selection kit plus additional custom-made reference genes (PrimerDesign Ltd.) and analyzed using the geNorm software (48), and the results were produced as relative expression level with lowest expression equal to one.
###end p 66
###begin p 67
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysf</italic>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For the qPCR data, two-way ANOVA was used to determine if there was any statistically significant difference in relative expression levels over time for each analyzed mRNA between C57BL/10 and C57BL/10.SJL-Dysf. A P-value < 0.05 was considered significant.
###end p 67
###begin title 68
Analysis of inflammatory cell recruitment
###end title 68
###begin p 69
###xml 380 381 380 381 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 386 387 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 885 887 879 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 892 894 886 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 903 905 897 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 911 913 905 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 951 952 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 958 961 952 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 62 66 <span type="species:ncbi:10090">Mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
Inflammatory cell recruitment was analysed by flow cytometry. Mice (generally four per time point) were sacrificed 1, 2, 3, 4 and 7 days after notexin injection (non-injected mice were used as controls). Fascia of the TA was removed. Muscles were dissociated in PBS containing collagenase D 1.5 U/ml (Roche Diagnostics GmbH), dispase II 2.4 U/ml (Roche Diagnostics GmbH) and 2.5 mm CaCl2, incubated at 37degreesC for 1 h, filtered and counted. Cells were stained with PerCP-Cy5.5-conjugated anti-CD45 (BD Biosciences), Alex647-conjugated anti-F4/80 (AbD Serotec) and FITC-conjugated Ly6C (BD Biosciences) antibodies. Analysis was performed with an LSRII cytometer (BD Biosciences). The numbers of monocytes and neutrophils were calculated as the total cells multiplied by the percentage of cells within the gate. Within this population, monocyte subsets were identified as either F4/80lo/Ly6Chi or F4/80hi/Ly-6Clo. Neutrophils were identified as F4/80-/Ly-6Cint. Total cell numbers were normalized to TA weight.
###end p 69
###begin title 70
Primary myoblast culture and cytokine release assay
###end title 70
###begin p 71
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 376 377 376 377 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 382 383 382 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 462 463 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 747 748 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:9913">calf</span>
###xml 575 580 <span type="species:ncbi:9606">human</span>
###xml 1053 1057 <span type="species:ncbi:9913">calf</span>
###xml 1233 1238 <span type="species:ncbi:9796">horse</span>
Primary myoblast cultures were isolated and cultured using standard techniques. Briefly, limb muscles were carefully removed from two to three neonatal mice and placed immediately in PBS. In a laminar flow cabinet, the muscles were minced to slurry, treated with collagen/dispase/CaCl2 solution, containing 1.5 U/ml collagenase D (Roche), 2.4 U/ml dispase II (Roche) and 2.5 mm CaCl2, and incubated at 37degreesC for 25 min. After centrifugation for 5 min at 350g, the cells were resuspended in Ham's F-10 (Invitrogen) containing 20% fetal calf serum (Invitrogen), 2.5 ng/ml human basic fibroblast growth factor (Promega), 100 U/ml penicillin and 100 microg/ml streptomycin. The cells were cultured on collagen-coated flasks at 37degreesC in 5% CO2 incubator and the growth medium was changed every 2 days. After four to five passages, most of the fibroblasts were eliminated from the culture and myoblasts were grown by replacing the F-10 based growth medium to F-10/DMEM-based primary myoblast growth medium (40% of Ham's F-10, 40% of DMEM, 20% fetal calf serum, 2.5 ng/ml basic fibroblast growth factor and 100 U/ml penicillin and 100 microg/ml streptomycin). For fusion assays, the medium was substituted with DMEM containing 5% horse serum and 100 U/ml penicillin and 100 microg/ml streptomycin. Primary myoblasts were cultured in a 24 well plate for 2 days before stimulation with 200 U/ml IFN-gamma or wounding with 0.005% saponin. The medium and cells were harvested 24 h after stimulation and MCP-1 concentration was analyzed by ELISA (R&D Systems).
###end p 71
###begin title 72
SUPPLEMENTARY MATERIAL
###end title 72
###begin p 73

###end p 73
###begin title 74
Supplementary Material
###end title 74
###begin title 75
[Supplementary Data]
###end title 75
###begin title 76
ACKNOWLEDGEMENTS
###end title 76
###begin p 77
###xml 586 593 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
We would like to thank Neil Hamilton and Steve Smith for technical support, Dr Clare Jeffray and Dr Ian Gibb (Royal Victoria Infirmary, Newcastle) for performing the CK analysis, Professors John Harris and Clarke Slater for their advice concerning notexin, Dr Emilie Groen for an initial analysis of the LGMD2A data, Professor John Mathers for use of the treadmill, Ian Dimmick and Dr Rebecca Stewart for help with flow cytometry, Dr Andrew Roddam (University of Oxford) for help and advice with the statistical analysis and Dr Paul Sharp (Imperial College, London) for training in the in situ force measurement protocol. The authors also thank the National Commissioning Group (NCG) for supporting the diagnostic work in the LGMD population. This work was supported by Action Medical Research (UK), AFM (France), Deutsche Forschungsgemeinschaft (KL 1868/1-1 and 2-1 to L.K.), the Jain Foundation (USA), the Lundbeck Foundation (Denmark), Science City Newcastle, MRC (UK) as part of the MRC Centre for Neuromuscular Diseases and the Muscular Dystrophy Campaign (UK). Newcastle University is the coordinating partner of the TREAT-NMD network of excellence (EC 036825).
###end p 77
###begin p 78
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 78
###begin title 79
REFERENCES
###end title 79
###begin article-title 80
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy
###end article-title 80
###begin article-title 81
###xml 18 40 18 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 18 40 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B
###end article-title 81
###begin article-title 82
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype
###end article-title 82
###begin article-title 83
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes
###end article-title 83
###begin article-title 84
Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation
###end article-title 84
###begin article-title 85
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients
###end article-title 85
###begin article-title 86
A nematode gene required for sperm vesicle fusion
###end article-title 86
###begin article-title 87
Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains
###end article-title 87
###begin article-title 88
Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle
###end article-title 88
###begin article-title 89
Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing
###end article-title 89
###begin article-title 90
Dysferlin interacts with affixin (beta-parvin) at the sarcolemma
###end article-title 90
###begin article-title 91
Regulated exocytosis: a novel, widely expressed system
###end article-title 91
###begin article-title 92
Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis
###end article-title 92
###begin article-title 93
Requirement for annexin A1 in plasma membrane repair
###end article-title 93
###begin article-title 94
Caveolin regulates endocytosis of the muscle repair protein, dysferlin
###end article-title 94
###begin article-title 95
Defective membrane repair in dysferlin-deficient muscular dystrophy
###end article-title 95
###begin article-title 96
Dysferlin in membrane trafficking and patch repair
###end article-title 96
###begin article-title 97
MG53 nucleates assembly of cell membrane repair machinery
###end article-title 97
###begin article-title 98
MG53 regulates membrane budding and exocytosis in muscle cells
###end article-title 98
###begin article-title 99
Cellular and molecular regulation of muscle regeneration
###end article-title 99
###begin article-title 100
Inflammatory cell response to acute muscle injury
###end article-title 100
###begin article-title 101
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth
###end article-title 101
###begin article-title 102
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
###end article-title 102
###begin article-title 103
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 129 143 <span type="species:ncbi:8722">Bothrops asper</span>
Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom
###end article-title 103
###begin article-title 104
Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study
###end article-title 104
###begin article-title 105
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo
###end article-title 105
###begin article-title 106
###xml 131 135 <span type="species:ncbi:10090">mice</span>
The differential gene expression profiles of proximal and distal muscle groups are altered in pre-pathological dysferlin-deficient mice
###end article-title 106
###begin article-title 107
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury
###end article-title 107
###begin article-title 108
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Proceedings: histological and histochemical aspects of the effect of notexin on rat skeletal muscle
###end article-title 108
###begin article-title 109
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine
###end article-title 109
###begin article-title 110
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Absence of dysferlin alters myogenin expression and delays human muscle differentiation 'in vitro
###end article-title 110
###begin article-title 111
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice
###end article-title 111
###begin article-title 112
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro
###end article-title 112
###begin article-title 113
M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury
###end article-title 113
###begin article-title 114
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Phagocytosis of necrotic muscle in muscle isografts is influenced by the strain, age, and sex of host mice
###end article-title 114
###begin article-title 115
Fatigue and muscle-tendon stiffness after stretch-shortening cycle and isometric exercise
###end article-title 115
###begin article-title 116
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
###end article-title 116
###begin article-title 117
Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle
###end article-title 117
###begin article-title 118
Dysferlin expression in monocytes: a source of mRNA for mutation analysis
###end article-title 118
###begin article-title 119
Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B
###end article-title 119
###begin article-title 120
MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration
###end article-title 120
###begin article-title 121
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2-/- mice following ischemic injury
###end article-title 121
###begin article-title 122
###xml 47 52 <span type="species:ncbi:9606">human</span>
Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation
###end article-title 122
###begin article-title 123
From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis
###end article-title 123
###begin article-title 124
Dysferlin and the plasma membrane repair in muscular dystrophy
###end article-title 124
###begin article-title 125
Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression
###end article-title 125
###begin article-title 126
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
###end article-title 126
###begin article-title 127
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
###end article-title 127

